
CRISPR Therapeutics AG (CRSP) last year’s performance of -29.63% is a clear signal for an entertaining trading season.
On Tuesday, CRISPR Therapeutics AG (NASDAQ: CRSP) opened higher 2.95% from the last session, before settling in for the closing price of $36.95. Price fluctuations